Literature DB >> 35104445

Systematic Review of Functional Outcomes in Cancer Rehabilitation.

Alix Sleight1, Lynn H Gerber2, Timothy F Marshall3, Alicia Livinski4, Catherine M Alfano5, Shana Harrington6, Ann Marie Flores7, Aneesha Virani8, Xiaorong Hu9, Sandra A Mitchell10, Mitra Varedi11, Melissa Eden12, Samah Hayek13, Beverly Reigle14, Anya Kerkman15, Raquel Neves16, Kathleen Jablonoski17, Eileen Danaher Hacker18, Virginia Sun19, Robin Newman20, Karen Kane McDonnell21, Allison L'Hotta22, Alana Schoenhals23, Nicole L Stout Dpt24.   

Abstract

OBJECTIVE: To systematically review the evidence regarding rehabilitation interventions targeting optimal physical or cognitive function in adults with a history of cancer and describe the breadth of evidence as well as strengths and limitations across a range of functional domains. DATA SOURCES: PubMed, Cumulative Index to Nursing and Allied Health Plus, Scopus, Web of Science, and Embase. The time scope was January 2008 to April 2019. STUDY SELECTION: Prospective, controlled trials including single- and multiarm cohorts investigating rehabilitative interventions for cancer survivors at any point in the continuum of care were included, if studies included a primary functional outcome measure. Secondary data analyses and pilot/feasibility studies were excluded. Full-text review identified 362 studies for inclusion. DATA EXTRACTION: Extraction was performed by coauthor teams and quality and bias assessed using the American Academy of Neurology (AAN) Classification of Evidence Scheme (class I-IV). DATA SYNTHESIS: Studies for which the functional primary endpoint achieved significance were categorized into 9 functional areas foundational to cancer rehabilitation: (1) quality of life (109 studies), (2) activities of daily living (61 studies), (3) fatigue (59 studies), (4) functional mobility (55 studies), (5) exercise behavior (37 studies), (6) cognition (20 studies), (7) communication (10 studies), (8) sexual function (6 studies), and (9) return to work (5 studies). Most studies were categorized as class III in quality/bias. Averaging results found within each of the functional domains, 71% of studies reported statistically significant results after cancer rehabilitation intervention(s) for at least 1 functional outcome.
CONCLUSIONS: These findings provide evidence supporting the efficacy of rehabilitative interventions for individuals with a cancer history. The findings should be balanced with the understanding that many studies had moderate risk of bias and/or limitations in study quality by AAN criteria. These results may provide a foundation for future work to establish clinical practice guidelines for rehabilitative interventions across cancer disease types.
Copyright © 2022. Published by Elsevier Inc.

Entities:  

Keywords:  Functional status; Neoplasms; Rehabilitation; Systematic review

Mesh:

Year:  2022        PMID: 35104445      PMCID: PMC9339032          DOI: 10.1016/j.apmr.2022.01.142

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   4.060


  3 in total

1.  Usability, acceptability, and implementation strategies for the Exercise in Cancer Evaluation and Decision Support (EXCEEDS) algorithm: a Delphi study.

Authors:  Kelley C Wood; Mackenzi Pergolotti; Tim Marshall; Heather J Leach; Julia L Sharp; Grace Campbell; Grant R Williams; Jack B Fu; Tiffany D Kendig; Nancy Howe; Anita Bundy
Journal:  Support Care Cancer       Date:  2022-05-26       Impact factor: 3.359

2.  Feasibility and Impact of Adapted Physical Activity (APA) in Cancer Outpatients Beginning Medical Anti-Tumoral Treatment: The UMA-CHAPA Study.

Authors:  Amélie Lemoine; Marine Perrier; Camille Mazza; Anne Quinquenel; Mathilde Brasseur; Alain Delmer; Hervé Vallerand; Maxime Dewolf; Eric Bertin; Coralie Barbe; Damien Botsen; Olivier Bouché
Journal:  Cancers (Basel)       Date:  2022-04-14       Impact factor: 6.575

Review 3.  Integrating molecular biomarkers in breast cancer rehabilitation. What is the current evidence? A systematic review of randomized controlled trials.

Authors:  Marco Invernizzi; Lorenzo Lippi; Arianna Folli; Alessio Turco; Lorenzo Zattoni; Antonio Maconi; Alessandro de Sire; Nicola Fusco
Journal:  Front Mol Biosci       Date:  2022-09-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.